OR WAIT 15 SECS
© 2021 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
As more people are working and staying active later in life, interest in presbyopia-correcting IOLs among cataract surgery patients seems to be growing. At the same time, not all patients are aware of this option. Sheri Rowen, MD, explains how she educates patients about presbyopia-correcting IOLs and the value of premium cataract surgery. She also describes elements of the preoperative clinical examination that are key for patient selection.
Read the article now